Sanofi SA (SAN) Given a €95.00 Price Target at Deutsche Bank AG
Sanofi SA (EPA:SAN) has been given a €95.00 ($105.56) price target by analysts at Deutsche Bank AG in a report released on Thursday. The brokerage currently has a a “buy” rating on the stock.
Other equities analysts also recently issued reports about the stock. Jefferies Group set a €74.00 ($82.22) price target on shares of Sanofi SA and gave the company a “neutral” rating in a report on Thursday. Kepler Capital Markets set a €91.00 ($101.11) target price on shares of Sanofi SA and gave the stock a “buy” rating in a research note on Thursday, July 7th. JPMorgan Chase & Co. set a €71.00 ($78.89) target price on shares of Sanofi SA and gave the stock a “sell” rating in a research note on Thursday, September 15th. Berenberg Bank set a €93.00 ($103.33) target price on shares of Sanofi SA and gave the stock a “buy” rating in a research note on Thursday, September 8th. Finally, Societe Generale set a €100.00 ($111.11) target price on shares of Sanofi SA and gave the stock a “buy” rating in a research note on Monday, August 1st. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and seven have assigned a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average target price of €86.18 ($95.75).
Shares of Sanofi SA (EPA:SAN) traded down 1.12% during mid-day trading on Thursday, reaching €67.71. 1,768,014 shares of the company were exchanged. The firm has a 50-day moving average price of €25.98 and a 200 day moving average price of €25.76. The stock has a market capitalization of €87.14 billion and a P/E ratio of 21.05. Sanofi SA has a 12 month low of €22.81 and a 12 month high of €68.17.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/13/sanofi-sa-san-given-a-95-00-price-target-at-deutsche-bank-ag.html
About Sanofi SA
Sanofi, formerly Sanofi-Aventis, is a healthcare company engaged in the research, development, manufacture and marketing of therapeutic solutions. The Company operates through three segments: Pharmaceuticals, Human Vaccines (Vaccines) and Animal Health. The Pharmaceuticals segment consists of research, development, production and marketing of medicines, including those originating from Genzyme Corporation.
Receive News & Ratings for Sanofi SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi SA and related companies with MarketBeat.com's FREE daily email newsletter.